The Importance of COVID-19/Influenza Vaccines Co-Administration: An Essential Public Health Tool
Roberto Venuto, Ioselita Giunta, Rosaria Cortese, Federica Denaro, Giuseppe Pantò, Antonino Carlo Privitera, Smeralda D’Amato, Cristina Genovese, Vincenza La Fauci, Francesco Fedele, Concetta Ceccio, Raffaele Squeri, Alessio Facciolà
Abstract
Vaccine co-administration is an important tool with several advantages for public health, among which is the increase of vaccination coverage, as well as economic and logistical benefits. The purpose of this study was to assess and compare the immune response to the COVID-19 first booster dose in healthcare workers (HCWs) who chose co-administration and in HCWs who received only COVID-19 vaccination and to investigate personal opinions about the experience of co-administration. We carried out a retrospective analysis involving two groups of HCWs, both vaccinated with the complete primary cycle and the first booster dose of the COVID-19 vaccine, but one of them was also vaccinated, at the same time as the first booster dose, with the influenza vaccine. Active phone calls were also performed, and specific questions about the onset of side effects and general opinions were asked. A good immune response was found in both two groups without any statistically significant difference in the immune response. No severe reactions occurred in either group. A greater part of the sample was completely satisfied, and they would do it again. Our findings are totally in favor of the co-administration, considering the many positive aspects provided by administering, at the same time, more vaccines.